2 results
Approved WMOCompleted
This study aims to test the hypothesis that zandelisib in combination with rituximab has better clinical activity and risk/benefit profile compared to standard 2nd line immunochemotherapy (R-CHOP/R-B) in subjects with relapsed FL or MZL. Primary…
Approved WMORecruiting
Our overall aim is to measure several distinct MR parameters at 0.064 Tesla, and to use these to derive optimal MRI-protocols in terms of contrast and SNR. Some of these new developments may subsequently be used in clinical research protocols (which…